C2 by-pass: Cross-talk between the complement classical and alternative pathways
Author
Laich, A
Patel, H
Zarantonello, A
Sim, R B
Inal, J M
Attention
2299/26676
Abstract
Several disorders associated with the total or partial absence of components of the human complement system are known. Deficiencies of classical pathway (CP) components are generally linked to systemic lupus erythematosus (SLE) or SLE-like syndromes. However, only approximately one-third of patients who lack C2 show mild symptoms of SLE. The relatively high frequency of homozygous C2 deficiency without or with minor disease manifestation suggests that there might be a compensatory mechanism which allows the activation of the CP of complement without the absolute requirement of C2. In this study we show that factor B (FB), the C2 homologue of the alternative pathway (AP) of complement, can substitute for C2. This was confirmed by using C4b as immobilised ligand and FB as analyte in Surface Plasmon Resonance (BIACORE). C2 binding to the immobilised C3b-like molecule C3(CH 3NH 2) was not seen. The estimated binding constant for C4bB complex formation was 2.00 * 10 -5 [M]. We were further able to demonstrate that C4b supports the cleavage of Factor B by Factor D. Finally, cleavage of 125I-C3 by C4bBb was evaluated and gave strong evidence that the "hybrid" convertase C4bBb can cleave and activate C3 in vitro. Cleavage activity is very low, but consistent with some of the "C2-bypass" observations of others.
Publication date
2022-05-31Published in
ImmunobiologyPublished version
https://doi.org/10.1016/j.imbio.2022.152225Other links
http://hdl.handle.net/2299/26676Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi
Cestari, Igor Dos S; Evans-Osses, Ingrid; Freitas, Juliana C; Inal, Jameel M; Ramirez, Marcel I (2008-11-01)The ability to resist complement differs between the Y and Colombiana Trypanosoma cruzi strains. We found that the Y strain of T. cruzi was more able to resist the classical and lectin pathways of complement activation ... -
An induced population of Trypanosoma cruzi epimastigotes more resistant to complement lysis promotes a phenotype with greater differentiation, invasiveness, and release of extracellular vesicles
Rossi , Izadora Volpato; Nunes, Maria Alice Ferreira; Sabatke, Bruna; Ribas , Hennrique Taborda; Winnischofer , Sheila Maria Brochado; Ramos, Augusto Savio Peixoto; Ramirez, Marcel Ivan; Inal, Jameel (2022-12-14)Introduction: Chagas disease is a neglected tropical disease caused by Trypanosoma cruzi, which uses blood-feeding triatomine bugs as a vector to finally infect mammalian hosts. Upon entering the host, the parasite needs ... -
Solid-phase microextraction for assessment of plasma protein binding, a complement to rapid equilibrium dialysis
Sheelan, Ahmad,; Baker, Daniel; Murnane, Darragh; Neil, Spooner,; Gerhard, Ute (2021-07-19)Aim: Determination of plasma protein binding (PPB) is considered vital for better understanding of pharmacokinetic and pharmacodynamic activities of drugs due to the role of free concentration in pharmacological response. ...